Items where authors include "Goodman, A."
Up a levelArticle
Sacco, J.J., Jackson, R., Corrie, P. et al. (18 more authors) (2024) A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma. European Journal of Cancer, 202. 114009. ISSN 0959-8049
Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326
Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326
Fenstermacher, M. E., Abbate, J., Abe, S. et al. (827 more authors) (2022) DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy. Nuclear Fusion. 042024. ISSN 1741-4326
Corrie, P.G., Marshall, A., Nathan, P.D. et al. (36 more authors) (2018) Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Annals of Oncology, 29 (8). pp. 1843-1852.
Book Section
Goodwin, S.P., Kroupa, P., Goodman, A. et al. (1 more author) (2007) The Fragmentation of Cores and the Initial Binary Population. In: Reipurth, B., Jewitt, D. and Keil, K., (eds.) Protostars and Planets V. University of Arizona Press , Tucson , pp. 133-147. ISBN 978-0-8165-2654-3